EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.26X leverage
Performance
- Low
- ₹1,539
- High
- ₹1,575
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,575
- Open Price₹1,551
- Previous Close₹1,551
- Volume310,254
- 50 DMA₹1,427.82
- 100 DMA₹1,393.29
- 200 DMA₹1,362.76
Investment Returns
- Over 1 Month + 9.18%
- Over 3 Month + 17.3%
- Over 6 Month + 15.89%
- Over 1 Year + 16.23%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 37.5
- PEG Ratio
- 0.9
- Market Cap Cr
- 29,774
- P/B Ratio
- 6.3
- Average True Range
- 52.6
- EPS
- 42.32
- Dividend Yield
- 0.2
- MACD Signal
- 28.24
- RSI
- 67.78
- MFI
- 69.14
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,570.60
+
20
(1.29%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,472.99
- 50 Day
- ₹1,427.82
- 100 Day
- ₹1,393.29
- 200 Day
- ₹1,362.76
Resistance and Support
1561.6
- R3 1,619.80
- R2 1,597.40
- R1 1,584.00
- S1 1,548.20
- S2 1,525.80
- S3 1,512.40
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,570 As on 15 January, 2026 | 15:31
The Market Cap of Emcure Pharmaceuticals is ₹29774.3 Cr As on 15 January, 2026 | 15:31
The P/E ratio of Emcure Pharmaceuticals is 37.5 As on 15 January, 2026 | 15:31
The PB ratio of Emcure Pharmaceuticals is 6.3 As on 15 January, 2026 | 15:31
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.